Atara biotherapeutics to participate at the 7th annual evercore isi healthconx conference

Thousand oaks, calif.--(business wire)---- $atra #cart--atara biotherapeutics, inc. (nasdaq: atra), a leader in t-cell immunotherapy, leveraging its novel allogeneic epstein-barr virus (ebv) t-cell platform to develop transformative therapies for patients with cancer and autoimmune diseases, today announced that cokey nguyen, ph.d., president and chief executive officer, will participate in a fireside chat at the 7th annual evercore isi healthconx conference on tuesday, december 3, 2024, at 3:50 p.m. est. a li.
EVR Ratings Summary
EVR Quant Ranking